Accelerating your clinical program in Australia and APAC.
At Southern Star Research, we empower small and mid-sized biotech, pharmaceutical, and medical device companies to confidently navigate complex early-phase clinical development across APAC. As Australia’s trusted, independent mid-sized CRO, we offer the “sweet spot” advantage: substantial enough to provide comprehensive, globally recognized services, yet agile and client-focused for truly personalized engagement. While our core strength lies in Phase I and II trials, our proven experience and robust infrastructure ensure seamless progression into Phase III when your program demands it.
Our purpose and philosophy
Advancing your science with strategic clinical design and integrity.
Southern Star Research was founded by industry pioneers, driven by a profound commitment to intellectually engaged partnership, embedded quality, and principled action. This foundational philosophy continues to shape our culture today, guiding how we work, grow, and deliver exceptional outcomes for our clients, patients, and global health.
We view our role as more than service providers; we are your trusted advisors, sharing knowledge, offering guidance, and engaging in collaborative decision-making to strengthen your strategies and accelerate your outcomes.
We treat every protocol as a problem worth solving, not just a checklist to execute. Our teams bring critical thinking and domain expertise to bear on your specific challenges – contributing meaningfully rather than simply complying.
We define quality not just by compliance, but by the consistent application of judgment, rigor, and thoughtful planning throughout all stages of the clinical trial process, ensuring the highest ethical and scientific standards.
We adapt our ways of working to fit the needs of each client, protocol, and geography. This flexibility is delivered without compromising regulatory rigor, internal standards, or team cohesion.
We care deeply about our work, our clients, and the profound impact of clinical research. This care is supported by the mental effort and follow-through required to achieve your meaningful results.
We operate with unwavering honesty, accountability, and respect, upholding integrity in both visible decisions and unseen day-to-day actions. This includes declining opportunities that do not align with our ethical or scientific standards.
The values and purpose that shaped our founding – contributing to global research through clinical excellence in Australia and the Asia-Pacific region – continue to guide our choices, culture, and long-term growth.
Our track record
Proven expertise across diverse therapeutic areas.
Our team’s depth of experience and scientific understanding means we anticipate challenges early, adapt quickly, and generate data that stands up to global scrutiny; a critical factor for successful regulatory submissions and investor confidence.
For over 15 years, our highly qualified clinical team has successfully supported trials across a wide range of therapeutic areas, spanning both common and complex indications. This extensive experience ensures your program will benefit from insights built across diverse patient populations and clinical challenges.
Metabolic & lifestyle diseases: From diabetes to cholesterol, age-related metabolic disorders and osteoarthritis, our teams manage trials for conditions with significant global patient populations.
Neurological conditions: Specialized experience in central nervous system disorders, addressing unique patient challenges and complex outcome measures.
Healthy Volunteer: Phase 1 safety and pharmacology programs.
Oncology: Expert navigation of early-phase settings across multiple tumor types, understanding the nuances of novel therapies.
Trial rescue: Expert intervention and strategic redirection for studies facing complex operational or clinical challenges.
Vaccines: Successfully conducting vaccine trials with meticulous safety and immunogenicity endpoints.
Demonstrating our commitment to quality and our clients.
Our commitment to quality is validated by a 14-year track record and multiple industry accolades, including being named Best CRO in Australia, APAC CRO of the Year and maintaining ISO 9001:2015 certification with zero findings.
Our people
A highly qualified team driving excellence.
Southern Star Research is distinguished by the caliber, qualifications, and dedication of our expert team. Our team is built around seniority, not scale. Senior specialists with deep clinical development expertise remain close to your program throughout, not as oversight layers, but as active participants.
Help shape the health of the future: grow with our high-performing team.
Southern Star Research is rapidly growing, expanding our global footprint and pioneering early-phase clinical development across APAC.
We seek high-performing, motivated professionals eager to contribute to groundbreaking science within a culture of intellectual engagement and integrity. We cultivate a collaborative, learning environment with high staff loyalty, where your expertise will directly shape client outcomes and global health.
Accelerate your program with Australia’s unique benefits and tax incentives.
Secure costs up to 60% lower than the US or EU, underpinned by Australia’s R&D Tax Incentive program, which offers a cash rebate of up to 43.5% on eligible expenditures.
Benefit from a streamlined, predictable, and globally aligned regulatory landscape.
Generate regulator-ready data consistently recognized by major international bodies, including FDA, EMA, PMDA and Health Canada.
Tap into a wide range of patient populations, often with lower competing trials.
Compressed timelines between submission and site initiation significantly accelerate your program.
Advance your clinical program with confidence with Southern Star Research.
